[Retracted] The Use of Cytotoxic Drugs as First Line Chemotherapy for EGFR (+) Nonsquamous NSCLC: A Network Meta-Analysis

<div>NMA forest plot of OS. The differences among erlotinib, gefitinib, afatinib, cetuximab, and icotinib are not statistically significant. The NMA demonstrates that there is no statistically significant change in OS when the six different drugs are employed.</div>

Disease Markers

fig3

Figure 3

Figure 3: [Retracted] The Use of Cytotoxic Drugs as First Line Chemotherapy for EGFR (+) Nonsquamous NSCLC: A Network Meta-Analysis 